ONT-380 has stage IV HER2+ breast cancer patient 'worrying about normal stuff again'

… anti-cancer agent ONT-380 against HER2+ breast cancer, in one case specifically against … of the Breast Cancer Research Program and Young Women's Breast Cancer Translational … for patients with metastatic HER2-positive breast cancer More information: abstracts.asco.org …